Alzheimers Therapeutics Market
According to Intent Market Research, the Alzheimer’s Therapeutics Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 10.7% to touch USD 9.5 billion by 2030. The Alzheimer’s Therapeutics Market is dominated by key players such as Eli Lilly and Co., Biogen Inc., Roche Holding AG, Johnson & Johnson, Novartis AG, Pfizer Inc., AstraZeneca, Merck & Co., Inc., Sanofi S.A., GlaxoSmithKline PLC, Amgen Inc., Mitsubishi Tanabe Pharma, AbbVie Inc., H. Lundbeck A/S, Takeda Pharmaceutical Company.